1 Karam JH, Grodsky GM & Forsham PH. Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes 1963 12 197–204.
2 Perley M & Kipnis DM. Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects. Diabetes 1966 15 867–874.
3 Bagdade JD, Porte D Jr, Brunzell JD & Bierman EL. Basal and stimulated hyperinsulinism: reversible metabolic sequelae of obesity. Journal of Laboratory and Clinical Medicine 1974 83 563–569.
4 Bergman RN, Toffolo G, Bowden CR & Cobelli C. Minimal modeling, partition analysis and identification of glucose disposal in animals and man. In Proceedings of the International Conference on Cybernetics and Society (Cambridge, MA, October 1980), pp 129–135. IEEE Press. New York, NY, USA, 1980.
5 Bergman RN, Phillips LS & Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man. Journal of Clinical Investigation 1981 68 1456–1467.
6 Bergman RN, Ider YZ, Bowden CR & Cobelli C. Quantitative estimation of insulin sensitivity. American Journal of Physiology. Endocrinology and Metabolism 1979 236 E667–E677.
7 Toffolo G, Bergman RN, Finegood DT, Bowden CR & Cobelli C. Quantitative estimation of B-cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes 1980 29 979–990.
8 Johnston C, Raghu P, McCulloch DK, Beard JC, Ward WK, Klaff LJ et al. Beta-cell function and insulin sensitivity in nondiabetic HLA-identical siblings of insulin-dependent diabetics. Diabetes 1987 36 829–837.
9 Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergmann RN, Schwartz MW et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993 42 1663–1672.
10 Watanabe RM, Vølund A, Roy S & Bergman RN. Prehepatic B-cell secretion during the intravenous glucose tolerance test in humans: application of a combined model of insulin and C-peptide kinetics. Journal of Clinical Endocrinology and Metabolism 1989 69 790–797.
11 Pacini G. Mathematical models of insulin secretion in physiological and clinical investigations. Computer Methods and Programs in Biomedicine 1994 41 269–285.
12 Mari A. Mathematical modeling in glucose metabolism and insulin secretion. Current Opinion in Clinical and Nutritional Metabolic Care 2002 5 495–501.
13 Ahre´n B & Pacini G. Impaired adaptation of first phase insulin secretion in postmenopausal women with glucose intolerance. American Journal of Physiology. Endocrinology and Metabolism 1997 273 E701–E707.
14 Larsson H & Ahre´n B. Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women. Diabetologia 2000 43 194–202.
15 Larsson H & Ahre´n B. Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. Diabetes Care 2000 23 650–657.
16 Guldstrand M, Ahre´n B & Adamson U. Improved b-cell function after standardized weight reduction in severely obese subjects. American Journal of Physiology. Endocrinology and Metabolism 2003 284 E557–E565.
17 Filipsson K, Pacini G, Scheurink AJW & Ahre´n B. PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice. American Journal of Physiology. Endocrinology and Metabolism 1998 274 E834–E842.
18 Pacini G, Thomaseth K & Ahre´n B. Contribution to glucose intolerance of insulin-independent vs. insulin-dependent mechanisms in mice. American Journal of Physiology. Endocrinology and Metabolism 2001 281 E693–E703.
19 Ahre´n B & Pacini G. Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice. American Journal of Physiology. Endocrinology and Metabolism 2002 283 E738–E744.
20 Ahre´n B & Pacini G. Dose-related effects of GLP-1 on insulin secretion, insulin sensitivity, and glucose effectiveness in mice. American Journal of Physiology. Endocrinology and Metabolism 1999 277 E996–E1004.
21 Bergman RN, Finegood DT & Ader M. Assessment of insulin sensitivity in vivo. Endocrine Reviews 1985 6 45–86.
22 Ward WK, Beard J & Porte D Jr. Islet beta cell function in human subjects. In Methods in Diabetes Research, vol 2, Clinical Methods, pp 3–14. Eds WL Clarke, J Larner & SL Pohl. New York: Wiley, 1986.
23 Ferrannini E & Mari A. How to measure insulin sensitivity. Journal of Hypertension 1998 16 895–906.
24 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412–419.
25 Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism 2000 85 2402–2410.
26 DeFronzo RA, Tobin JD & Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology. Endocrinology and Metabolism 1979 237 E214–E223.
27 Pacini G & Mari A. Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Practice in Research and Clinical Endocrinology and Metabolism 2003 17 305–322.
28 Bergman RN. Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 1989 38 1512–1527.
29 Pacini G, Tonolo G, Sambataro M, Maioli M, Ciccarese M, Brocco E et al. Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. American Journal of Physiology. Endocrinology and Metabolism 1998 274 E592–E599.
30 Natalucci S, Ruggeri P, Cogo CE, Picchio V & Burattini R. Insulin sensitivity and glucose effectiveness estimated by the minimal model technique in spontaneously hypertensive and normal rats. Experimental Physiology 2000 85 775–781.
31 Gresl TA, Colman RJ, Roecker EB, Havighurst TC, Huang Z, Allison DB et al. Dietary restriction and glucose regulation in aging rhesus monkeys: a follow-up report at 8.5 yr. American Journal of Physiology. Endocrinology and Metabolism 2001 281 E757–E765.
32 Finegood DT, Hramiak IM & Dupre J. A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. Journal of Clinical Endocrinology and Metabolism 1990 70 1538–1549.
33 Welch S, Gebhart SSP, Bergman RN & Phillips LS. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. Journal of Clinical Endocrinology and Metabolism 1990 71 1508–1518.
34 Beard JC, Bergman RN, Ward WK & Porte D Jr. The insulin sensitivity index in nondiabetic man. Correlation between clampderived and IVGTT-derived values. Diabetes 1986 35 362–369.
35 Matsuda M & DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999 22 1462–1470.
36 Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Ja¨rvinen H, van Haeften T et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000 23 295–301.
37 Mari A, Pacini G, Murphy E, Ludvik B & Nolan JJ. A model-based method for assessing insulin sensitivity from oral glucose tolerance test. Diabetes Care 2001 24 539–548.
38 Ward WK, Bolgiano DC, McKnight B, Halter JB & Porte D Jr. Diminished B cell secretory capacity in patients with noninsulin- dependent diabetes mellitus. Journal of Clinical Investigation 1984 74 1318–1328.
39 Larsson H & Ahre´n B. Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine. Diabetologia 1998 41 772–777.
40 Larsson H & Ahre´n B. Islet dysfunction in obese women with impaired glucose tolerance. Metabolism 1996 45 502–509.
41 Larsson H & Ahre´n B. Insulin resistant subjects lack islet adaptation to acute dexamethasone-induced reduction in insulin sensitivity. Diabetologia 1999 42 936–943.
42 Weyer C, Bogardus C, Mott DM & Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. Journal of Clinical Investigation 1999 104 787–794.
43 Kahn SE. The relative contributions of insulin resistance and beta cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003 46 3–19.
44 Ahre´n B & Thorsson O. Increased insulin sensitivity is associated with reduced insulin and glucagon secretion and increased insulin clearance in man. Journal of Clinical Endocrinology and Metabolism 2003 88 1264–1270.
45 Cerasi E & Luft R. The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. Acta Endocrinologica 1967 55 278–304.
46 Porte D Jr. Beta cells in type II diabetes mellitus. Diabetes 1991 40 166–180.
47 McGarry JD & Dobbins RL. Fatty acids, lipotoxicity and insulin secretion. Diabetologia 1999 42 128–138.
48 Ahre´n B. Autonomic regulation of islet hormone secretion – implications for health and disease. Diabetologia 2000 43 393–410.
49 Weyer C, Salbe AD, Lindsay RS, Pratley RE, Bogardus C & Tataranni P. Exaggerated pancreatic polypeptide secretion in Pima Indians: can an increased parasympathetic drive to the pancreas contribute to hyperinsulinemia, obesity, and diabetes in humans? Metabolism 2001 50 223–230.
50 van Citters GW, Kabir M, Kim SP, Mittelman SD, Dea MK, Brubaker PL et al. Elevated glucagon-like peptide-1-(7–36)- amide, but not glucose, associated with hyperinsulinemic compensation for fat feeding. Journal of Clinical Endocrinology and Metabolism 2002 87 5191–5198.
51 Kanauchi M, Yamano S, Kanauki K & Saito Y. Homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index, and oral glucose insulin sensitivity index in nonobese, nondiabetic subjects with high-normal blood pressure. Journal of Clinical Endocrinology and Metabolism 2003 88 3444–3446.
52 Phillips DI, Clark PM, Hales CN & Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabetic Medicine 1994 11 286–292.
53 Kautzky-Willer A, Krssa´k M,Winzer C, Pacini G, Tura A, Farhan S et al. Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 2003 52 244–251.
54 Porte D Jr. Normal physiology and phenotypic characterization of beta cell function in subjects at risk for non-insulin-dependent diabetes mellitus. Diabetic Medicine 1996 13 S25–S32.